Reading CVKD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CVKD free→Reading CVKD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CVKD free→QuarterlyIQ Insights · CVKD
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 28, 2026, Cadrenal Therapeutics, Inc. (the “Company”) and Matthew K. Szot mutually agreed to his transition from the role of Chief Financial Officer, effective May 28, 2026. Effective immediately after Mr. Szot’s termination, the Company appointed Quang X. Pham, its Chief Executive Officer, as interim Chief Financial Officer and interim Prin…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.